Cefuroxime

Active ingredient description

Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Cefuroxime
J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DC Second-generation cephalosporins
Discover more medicines within J01DC02

Medicines

Cefuroxime is the active ingredient of these drugs:

Drug
Countries

Hong Kong

Ireland

Austria France Hong Kong Netherlands United Kingdom

Hong Kong

Cyprus Hong Kong Lithuania Singapore

Singapore

Hong Kong

Ireland

Singapore

Cyprus Germany

Hong Kong

Hong Kong

Hong Kong

Austria

Hong Kong

Germany

Hong Kong

Hong Kong

France

Cyprus

Brazil

Brazil

Spain

Lithuania

Lithuania

Hong Kong

Singapore

Austria Lithuania Netherlands Spain

Hong Kong Lithuania Singapore

Hong Kong

Spain

Hong Kong

Brazil

Cyprus

Brazil Cyprus Hong Kong Ireland Lithuania

Australia Austria Brazil Cyprus France

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of product characteristics (SPC)
UK
Summary of product characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

O1R9FJ93ED - CEFUROXIME

CAS registry number

55268-75-2 - cefuroxime

56238-63-2 - Cefuroxime sodium

64544-07-6 - Cefuroxime axetil

SNOMED-CT

372833007 - Cefuroxime (substance)